Kylo Peptides

Kylo Peptides is a biotechnology company pioneering a platform for the intracellular delivery of peptide therapeutics. The company's proprietary technology enables the transport of large, complex peptides across cell membranes, addressing targets that were previously considered undruggable. By overcoming the limitations of traditional peptide delivery, Kylo aims to develop a new class of medicines for oncology and other therapeutic areas with high unmet needs. The company was founded within Versant Ventures' Inception Sciences incubator and is headquartered in San Diego. Its approach combines the high affinity and specificity of biologics with the cell-penetrating capabilities typically reserved for small molecules.